Earnings summaries and quarterly performance for AFLAC.
Executive leadership at AFLAC.
Daniel Amos
Chief Executive Officer
Audrey Tillman
Senior Executive Vice President and General Counsel
Bradley Dyslin
Executive Vice President and Global Chief Investment Officer; President, Aflac Global Investments
Max Brodén
Senior Executive Vice President and Chief Financial Officer
Virgil Miller
President, Aflac Incorporated; President, Aflac U.S.
Board of directors at AFLAC.
Arthur Collins
Director
Georgette Kiser
Director
Joseph Moskowitz
Director
Karole Lloyd
Director
Katherine Rohrer
Director
Michael Forrester
Director
Miwako Hosoda
Director
Nobuchika Mori
Director
Thomas Kenny
Director
W. Paul Bowers
Lead Non-Management Director
Research analysts who have asked questions during AFLAC earnings calls.
John Barnidge
Piper Sandler
7 questions for AFL
Thomas Gallagher
Evercore
7 questions for AFL
Alex Scott
Barclays PLC
6 questions for AFL
Jack Matten
BMO Capital Markets
5 questions for AFL
Suneet Kamath
Jefferies
5 questions for AFL
Joel Hurwitz
Dowling & Partners Securities, LLC
4 questions for AFL
Ryan Krueger
KBW
4 questions for AFL
Wesley Carmichael
Autonomous Research
4 questions for AFL
Elyse Greenspan
Wells Fargo
3 questions for AFL
Jamminder Bhullar
JPMorgan Chase & Co.
3 questions for AFL
Wilma Jackson Burdis
Raymond James
3 questions for AFL
Jimmy Bhullar
JPMorgan Chase & Co.
2 questions for AFL
Michael Ward
Citi Research
2 questions for AFL
Nicholas Annitto
Wells Fargo & Company
2 questions for AFL
Wes Carmichael
Wells Fargo
2 questions for AFL
Wilma Burdis
Raymond James Financial
2 questions for AFL
Francis Matten
BMO Capital Markets
1 question for AFL
Joshua Shanker
Bank of America Merrill Lynch
1 question for AFL
Taylor Scott
BofA Securities
1 question for AFL
Recent press releases and 8-K filings for AFL.
- In 4Q25, net EPS (diluted) $2.64, down 22.8% y-o-y; adjusted EPS ex-FX $1.57, up 0.6% y-o-y.
- Adjusted ROE ex-FX remained 14.5%, and adjusted leverage ratio stood at 21.4%, within the target 20–25% range.
- Regulatory capital strong: Japan ESR with USP at 253% (target 170–230%), U.S. Combined RBC at 575% (target 350–450%).
- Returned $1.103 B to shareholders in 4Q25 via $800 M dividends and $303 M buybacks; 2026 pretax margin guidance: Japan 33–36%, U.S. 17–20%.
- Aflac delivered adjusted EPS of $1.57, up 0.6% year-over-year, with an adjusted ROE of 11.7% (14.5% excluding foreign currency) and adjusted book value per share rising 0.5% excluding FX effects.
- Q4 segment results: Japan net earned premiums fell 1.9% (underlying –1.2%), with a 65% benefit ratio, 22% expense ratio, and 31.3% pre-tax margin; U.S. premiums rose 4%, with a 48.6% benefit ratio, 40.4% expense ratio, and 17.4% pre-tax margin.
- Capital deployment in Q4 included $800 million of share repurchases and $303 million of dividends; for full-year 2025, Aflac repurchased $3.5 billion of stock and paid $1.2 billion in dividends, returning $4.8 billion to shareholders.
- 2026 outlook: Japan underlying premiums down 1%–2%, benefit ratio 60%–63%, expense ratio 20%–23%, and pre-tax margin 33%–36%; U.S. net premium growth 3%–6% (lower end), benefit ratio 48%–52%, expense ratio 36%–39%, and pre-tax margin 17%–20%.
- Q4 EPS: net $2.64, adjusted $1.57; FY net $6.82, adjusted $7.49
- Aflac Japan: Q4 sales +15.7%, FY +16% driven by Moraito cancer product (+35.6%); persistency 93.1%
- Aflac U.S.: 2025 new sales $1.6 billion; premium persistency 79.2%; net earned premiums +2.9%
- Capital return: record $3.5 billion repurchases (33 M shares) & $1.2 billion dividends in 2025; Q1 2026 dividend +5.2%
- 2026 outlook: Japan underlying premiums –1% to –2%, expense ratio 20–23%, benefit ratio 60–63%, margin 33–36%; U.S. premium growth 3–6%, expense ratio 36–39%, benefit ratio 48–52%, margin 17–20%
- Q4 net EPS $2.64 and adjusted EPS $1.57; full-year net EPS $6.82 and adjusted EPS $7.49.
- Japan sales rose 15.7% in Q4 (16% in 2025) with persistency at 93.1%; net earned premiums declined 1.9% in Q4.
- Aflac U.S. new sales $1.6 billion in 2025 (over one-third in Q4); net earned premiums +2.9% and persistency 79.2%.
- Capital deployment: record $3.5 billion share repurchases and $1.2 billion dividends in 2025; Q4 repurchases $800 million, dividends $303 million; Q1 2026 dividend +5.2%.
- 2026 outlook: Japan underlying premiums −1% to −2%, expense ratio 20–23%, benefit ratio 60–63%, margin 33–36%; U.S. premiums +3–6%, benefit ratio 48–52%, expense ratio 36–39%, margin 17–20%.
- Aflac reported Q4 2025 total revenues of $4.9 billion and net earnings of $1.4 billion ($2.64 per diluted share), down from $5.4 billion and $1.9 billion ($3.42/share) in Q4 2024.
- Adjusted Q4 earnings were $818 million or $1.57 per diluted share, a 5.4% decline and a 0.6% increase ex-FX.
- The board raised the Q1 2026 dividend by 5.2% to $0.61 per share and repurchased $800 million of common stock in Q4, with 114.3 million shares still authorized.
- For the full year 2025, revenues fell 9.3% to $17.2 billion, with net earnings of $3.6 billion ($6.82/share), while adjusted EPS grew 3.5% ex-FX.
- In Q4 2025, total revenues were $4.9 billion (vs. $5.4 billion in Q4 2024) and net earnings were $1.4 billion, or $2.64 per diluted share (vs. $1.9 billion, $3.42).
- Adjusted earnings for the quarter were $818 million (–5.4% YoY) and adjusted EPS was $1.57 (+0.6%).
- For FY 2025, revenues declined 9.3% to $17.2 billion and net earnings were $3.6 billion ($6.82 per share), down from $5.4 billion ($9.63) in FY 2024.
- The board declared a Q1 2026 dividend of $0.61 per share, up 5.2%, payable March 2, 2026.
- Aflac repurchased $800 million of common stock (7.2 million shares) in Q4, with 114.3 million shares still authorized for buyback.
- Adjusted EPS of $1.57 in Q4 increased 0.6% year-over-year; adjusted book value per share up 0.5%, and adjusted ROE was 11.7% (14.5% excl. FX).
- Aflac Japan net earned premiums down 1.9% (underlying down 1.2%); benefit ratio improved to 65% and pre-tax margin was 31.3%; U.S. net premiums rose 4%, with a benefit ratio of 48.6% and pre-tax margin of 17.4%.
- Redeployed capital with $800 million of share repurchases and $303 million of dividends; ended Q4 with $4.1 billion of unencumbered liquidity, 21.4% adjusted leverage, SMR > 970%, ESR (USP) 253%, and RBC 575%.
- 2026 guidance:
- Japan: underlying premiums down 1–2%, expense ratio 20–23%, benefit ratio 60–63%, pre-tax margin 33–36%
- U.S.: net premium growth 3–6%, benefit ratio 48–52%, expense ratio 36–39%, pre-tax margin 17–20%.
- Adjusted EPS rose 0.6% YoY to $1.57, adjusted book value per share increased 0.5%, and adjusted ROE was 11.7% (14.5% ex-FX) in Q4 2025.
- Segment highlights: Japan net earned premiums fell 1.9% (underlying –1.2%), benefit ratio improved to 65%, expense ratio rose to 22%, pre-tax margin was 31.3%; U.S. net earned premiums grew 4%, benefit ratio was 48.6%, expense ratio 40.4%, pre-tax margin 17.4%.
- Capital and liquidity: repurchased $800 million of stock and paid $303 million in dividends; established $2 billion of off-balance-sheet PCAP trusts; holding-company unencumbered liquidity of $4.1 billion, adjusted leverage 21.4%; SMR >970%, ESR ~253% USP, RBC ~575%.
- 2026 outlook: Japan underlying earned premiums down 1–2%, expense ratio 20–23%, benefit ratio 60–63%, pre-tax margin 33–36%; U.S. net earned premium growth 3–6%, benefit ratio 48–52%, expense ratio 36–39%, pre-tax margin 17–20%.
- Q4 diluted net EPS was $2.64, down 22.8% YoY; adjusted diluted EPS was $1.57, up 0.6% YoY.
- GAAP ROE fell to 19.0% from 29.9% in Q4 2024; adjusted ROE ex-FX remained at 14.5%.
- Adjusted leverage ratio stood at 21.4%, within the 20–25% target range.
- Q4 capital deployment totaled $1,103 million, including $800 million in dividends and $303 million in share repurchases.
- For 2026, Aflac Japan targets a pretax profit margin of 33–36% while Aflac U.S. targets 17–20%.
- Adjusted EPS of $1.57, up 0.6% YoY (ex-FX)
- Japan segment: net earned premiums declined 1.9%; benefit ratio improved 150 bps to 65%; expense ratio rose 120 bps to 22%; pre-tax margin 31.3%
- U.S. segment: net earned premiums grew 4%; benefit ratio increased 230 bps to 48.6%; expense ratio at 40.4%; pre-tax margin 17.4%
- Capital deployment and strength: repurchased $800 M of stock and paid $303 M dividends; SMR > 970%, ESR 253%, RBC 575%
- 2026 guidance: Japan underlying premiums down 1–2%, benefit ratio 60–63%, expense ratio 20–23%, pre-tax margin 33–36%; U.S. premium growth 3–6%, benefit ratio 48–52%, expense ratio 36–39%, pre-tax margin 17–20%
Quarterly earnings call transcripts for AFLAC.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more
